The data is big,please wait a moment......
| EWAS ID | KEGG ID | Class | Disease/Phenotype [sample size n] |
Sample groups (case/control, trait, cell type etc.) |
KEGG Pathway Name | Pathway Gene Number | Gene Number Annotated In The KEGG Pathway | Pvalue | |
| Group1 [sample size n] |
Group2 [sample size n] |
||||||||
| EWAS332 | hsa00512 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Mucin type O-Glycan biosynthesis | 30 | 30 | 0 |
| EWAS332 | hsa00531 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Glycosaminoglycan degradation | 19 | 19 | 0 |
| EWAS332 | hsa00532 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate | 20 | 20 | 0 |
| EWAS332 | hsa00534 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 24 | 24 | 0 |
| EWAS332 | hsa00910 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Nitrogen metabolism | 17 | 17 | 0 |
| EWAS332 | hsa03430 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Mismatch repair | 23 | 23 | 0 |
| EWAS332 | hsa03450 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Non-homologous end-joining | 13 | 13 | 0 |
| EWAS332 | hsa04020 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Calcium signaling pathway | 178 | 176 | 1.42e-006 |
| EWAS332 | hsa04022 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
cGMP-PKG signaling pathway | 165 | 160 | 0.000879 |
| EWAS332 | hsa04080 | disease | lung cancer [n=136] |
lung carcinomas [n=124] |
Normal [n=12] |
Neuroactive ligand-receptor interaction | 273 | 269 | 4.07e-008 |